AMBRX, INC.

AMBRX, INC. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2003-01-01
Employees
101
Market Cap
-
Website
http://www.ambrx.com

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

First Posted Date
2021-09-13
Last Posted Date
2022-09-13
Lead Sponsor
Ambrx, Inc.
Registration Number
NCT05041972
Locations
🇺🇸

Mount Sinai Medical Center, Miami Beach, Florida, United States

🇺🇸

AMR Kansas City, Kansas City, Missouri, United States

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2021-04-02
Last Posted Date
2024-06-11
Lead Sponsor
Ambrx, Inc.
Target Recruit Count
71
Registration Number
NCT04829604
Locations
🇰🇷

Research Site, Suwon, Korea, Republic of

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

First Posted Date
2020-12-10
Last Posted Date
2024-11-29
Lead Sponsor
Ambrx, Inc.
Target Recruit Count
352
Registration Number
NCT04662580
Locations
🇺🇸

The Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

🇺🇸

UCSF, San Francisco, California, United States

🇺🇸

Urology Cancer Center, XCancer Research Network, Omaha, Nebraska, United States

and more 6 locations

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2017-08-21
Last Posted Date
2024-02-01
Lead Sponsor
Ambrx, Inc.
Target Recruit Count
106
Registration Number
NCT03255070
Locations
🇺🇸

USC Norris Cancer Hospital, Los Angeles, California, United States

🇺🇸

UCLA Hematology-Oncology, Santa Monica, California, United States

🇦🇺

Monash Health, Clayton, Victoria, Australia

and more 6 locations

Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-10-23
Last Posted Date
2009-10-12
Lead Sponsor
Ambrx, Inc.
Target Recruit Count
36
Registration Number
NCT00778518
Locations
🇭🇺

Accelsiors CRO and Consultancy Services, Budapest, Hungary

© Copyright 2024. All Rights Reserved by MedPath